Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

3 Reasons To Buy Actavis Plc

Actavis (NYSE:ACT) has become one of the largest pharmaceutical manufacturers in the world. Using a common strategy to become a big player in the medicine industry, Actavis avoided spending billions of dollars developing drugs from scratch and instead bought companies with already proven products like Warner Chilcott and Forest Labs. ACT's leadership has focused on launching generic drugs for patients with rare conditions─ the pharmaceutical version of a niche market. This strategy was successful in establishing a pipeline and was bolstered by Chilcott and Forest Lab's brand names. However, concerns about the upcoming expirations of those brands' patents put a damper on investor…